| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 20 |
| 1 | DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT) | 15 |
| 2 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 13 |
| 3 | DEXAMETHASONE | 12 |
| 4 | DEXAMETHASONE 1.5 MG | 12 |
| 5 | DIAZEPAM | 12 |
| 6 | ALPRAZOLAM | 11 |
| 7 | CARBOPLATIN | 10 |
| 8 | CARISOPRODOL | 10 |
| 9 | DARATUMUMAB | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPHEDRINE SULFATE | 10 | 0.0457 |
| 1 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 13 | 0.0425 |
| 2 | DIMETICONE | 1 | 0.0035 |
| 3 | LAZERTINIB | 1 | 0.0012 |
| 4 | AMIVANTAMAB-VMJW | 4 | 0.0011 |
| 5 | MEPERIDINE HYDROCHLORIDE | 10 | 0.0011 |
| 6 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| 7 | TOPOTECAN | 6 | 0.0010 |
| 8 | HYALURONATE SODIUM | 1 | 0.0007 |
| 9 | CLINDAMYCIN HYDROCHLORIDE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 18 |
| 1 | Platinum-based Drug [EPC] | 16 |
| 2 | Benzodiazepine [EPC] | 13 |
| 3 | Proton Pump Inhibitor [EPC] | 12 |
| 4 | Amide Local Anesthetic [EPC] | 11 |
| 5 | Antiarrhythmic [EPC] | 11 |
| 6 | General Anesthetic [EPC] | 11 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 8 | Muscle Relaxant [EPC] | 10 |
| 9 | Proteasome Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 1 | General Anesthetic [EPC] | 11 | 0.0003 |
| 2 | Muscle Relaxant [EPC] | 10 | 0.0002 |
| 3 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 6 | Amide Local Anesthetic [EPC] | 11 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Antiarrhythmic [EPC] | 11 | 0.0001 |